Results 301 to 310 of about 5,917,232 (403)

Bee Better: The Role of Honey in Modern Wound Care

Advanced Therapeutics, EarlyView.
The use of honey as a wound care agent is controversial but paradoxically increasingly popular. Honey possesses relevant antimicrobial properties and can modulate the immune system. The wound healing properties of honey likely depend on its composition and varies across wound types.
Léo‐Paul Tricou, Natalie Guirguis, Sarah Djebbar, Benjamin R. Freedman, Simon Matoori   +4 more
wiley   +1 more source

Fecal Microbiome and Urine Metabolome Profiling of Type 2 Diabetes. [PDF]

J Microbiol Biotechnol
Yi HM, Won S, Pak J, Park SE, Kim MR, Kim JH, Park EY, Hwang SY, Lee MH, Son HS, Kwak S.   +10 more
europepmc   +1 more source

Enhanced Epithelial Cell Uptake of Glycol Chitosan‐Coated PLGA Nanoparticles for Oral Drug Delivery

Advanced Therapeutics, EarlyView.
Here, glycol chitosan (GC)‐coated PLGA NPs are developed to enhance oral drug delivery by enabling dual‐pathway endocytosis via clathrin‐ and caveolae‐mediated mechanisms. Alginate layering coating on GC‐PLGA further improves oral insulin delivery, achieving sustained glucose reduction in diabetic mice.
Huiwen Pang, Wenxuan Yu, Youzhi Wu, Xuqiang Nie, Guojun Huang, Zhi Ping Xu, Chen Chen, Felicity Y. Han   +7 more
wiley   +1 more source

Insights into the molecular underpinning of type 2 diabetes complications. [PDF]

Hum Mol Genet
Singh A, Bocher O, Zeggini E.
europepmc   +1 more source

Treating type 2 diabetes in youth:a depressing picture [PDF]

, 2012
Pearson, E R
core   +1 more source

Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. [PDF]

, 2000
N Yabunaka, Jun Nishihira, Yuka Mizue, Moriya Tsuji, Momochika Kumagai, Yoshinori Ohtsuka, Masahiro Imamura, Masahiro Asaka   +7 more
openalex   +1 more source

On the Relentless Pursuit of an Oral Insulin Delivery System: How Far is Too Far?

Advanced Therapeutics, EarlyView.
Injectable insulin preparations have far outpaced oral ones by virtue of adequate bioavailability and are driven by innovations, including insulin pumps, real‐time blood glucose monitoring, and artificial intelligence. In contrast, oral insulin delivery systems, including nanomedicines, continue to struggle and lag due to varied reasons.
Sourav Bhattacharjee
wiley   +1 more source

Betatrophin in type 2 diabetes mellitus

Journal of Mahatma Gandhi Institute of Medical Sciences, 2013
Omprakash Gupta
doaj   +1 more source

Normoglycemia and Weight Reduction: Perspectives of People with Type 2 Diabetes in Australia. [PDF]

Patient Prefer Adherence
Newson RS, Barraclough H, Lapthorn J, Stewart M, Colman S, D'Emden M.   +5 more
europepmc   +1 more source

Combined high blood pressure and glucose in type 2 diabetes: double jeopardy

, 1998
C. E. Mogensen
openalex   +2 more sources